LQR-33084-74382
1 vaccination
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 805 / CO
- Registered
- 2021-06-23
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-06-23
Registered in v-safe
-
2021-06-23
Dose 1 — Janssen/Johnson & Johnson
-
2021-06-23
Survey response — day 0, dose 1MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-06-25
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-06-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-23 | Janssen/Johnson & Johnson | No |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release